Currently out of the existing stock ratings of Lawrence Keusch, 108 are a BUY (96.43%), 4 are a HOLD (3.57%).

Lawrence Keusch

Work Performance Price Targets & Ratings Chart

Analyst Lawrence Keusch, carries an average stock price target met ratio of 62.5% that have a potential upside of 16.63% achieved within 222 days.

Lawrence Keusch’s has documented 189 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on BDX, Becton Dickinson and Company at 04-Aug-2023.

Wall Street Analyst Lawrence Keusch

Analyst best performing recommendations are on HAE (HAEMONETICS).
The best stock recommendation documented was for HAE (HAEMONETICS) at 8/5/2020. The price target of $93 was fulfilled within 35 days with a profit of $16.89 (22.19%) receiving and performance score of 6.34.

Average potential price target upside

of $62.59 (20.67%) on TFX (TELEFLEX).
of $36.47 (21.33%) on SYK (STRYKER).
of $29.59 (14.38%) on ISRG (INTUITIVE SURGICAL).

AVNS Avanos Medical AVTR Avantor BAX Baxter International BDX Becton Dickinson and Company COO The Cooper Companies Common Stock HAE Haemonetics HRC Hill-Rom Holdings ISRG Intuitive Surgical MASI Masimo SYK Stryker TFX Teleflex ZBH Zimmer Biomet Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Rick Wise (STIFEL)